Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.79% | 89.35 | 1.3% | $810.33m | |
| AMGN | Amgen Inc. | 1.45% | 188.20 | 1.2% | $638.15m | |
| GILD | Gilead Sciences, Inc. | 0.52% | 65.89 | 0.9% | $484.79m | |
| BIIB | Biogen Inc. | 0.89% | 324.04 | 1.3% | $431.26m | |
| ILMN | Illumina, Inc. | 1.39% | 301.02 | 3.5% | $315.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.59% | 421.07 | 2.6% | $291.88m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.97% | 184.84 | 1.9% | $256.05m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.01% | 128.84 | 2.0% | $221.90m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.82% | 139.02 | 15.4% | $155.10m | |
| A | Agilent Technologies, Inc. | 0.09% | 77.96 | 1.6% | $150.94m | |
| EXAS | Exact Sciences Corporation | 8.71% | 90.54 | 25.3% | $143.81m | |
| INCY | Incyte Corporation | 1.19% | 84.32 | 2.5% | $113.26m | |
| ARRY | Array BioPharma Inc. | 3.39% | 23.48 | 8.2% | $111.67m | |
| EXEL | Exelixis, Inc. | 0.75% | 21.38 | 6.4% | $82.68m | |
| NBIX | Neurocrine Biosciences, Inc. | 1.79% | 78.69 | 5.1% | $78.60m |
Company Profile
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.